No Data
No Data
Up 127% in 2024, Why This ASX Healthcare Stock Is Surging Again This Month
It's been a decent start to both the month of July and the 2025 financial year for ASX shares so far.
New Zealand Shares Flat on US Rate Cut Hopes; Ebos Boosts MedAdvisor Stake
New Zealand shares were flat with positive bias on Wednesday's close as investors digested recent pronouncements from US Federal Reserve Chair Jerome Powell that rate cuts may potentially be back on t
Ebos Boosts MedAdvisor Stake; Says No Plan for Change of Control Proposal
Ebos Group (ASX:EBO, NZE:EBO) acquired 27.5 million shares in pharmaceutical software business MedAdvisor (ASX:MDR), increasing its stake to 9.8%, according to a Wednesday Australian bourse filing. Th
Private Companies Own 34% of MedAdvisor Limited (ASX:MDR) Shares but Individual Investors Control 36% of the Company
MedAdvisor Price Target Raised 4.3% to A$0.49/Share by Bell Potter
MedAdvisor Price Target Raised 4.3% to A$0.49/Share by Bell Potter
MedAdvisor Solutions Forecasts Continued Growth for FY25 After Stellar Year
MedAdvisor Solutions (ASX: MDR) is forecasting further strong growth over the next 12 months after achieving robust recent performances in sales and revenue.
No Data